Articles
| Open Access |
https://doi.org/10.37547/ijmscr/Volume02Issue11-01
STRUCTURAL AND FUNCTIONAL FEATURES OF THE MYOCARDIUM AGAINST THE BACKGROUND OF RENAL REPLACEMENT THERAPY
Abstract
Cardiovascular diseases are one of the most significant predictors of mortality in patients with end-stage renal disease treated with chronic hemodialysis, and cause at least a third of all hospitalizations [Eisner D. et al., 2001; Johnston N. et al., 2008]. According to the US Renal Disease Registry, the five-year survival rate in the general population of patients on hemodialysis is 33.4% [U. S. Renal Data System, 2009]. More than half of the deaths of patients on renal replacement therapy are due to cardiovascular pathology, the mortality from which in patients on
hemodialysis is 30-35 times higher compared to the general population [Zavy A.S. et al., 1998; Herzog S.A., 2003; U.S. Renal Data System, 2009]. A significant proportion of deaths in patients with end-stage renal disease receiving hemodialysis treatment are attributed to those associated with coronary heart disease [Foley R.N. et al., 1998a; Sarnak M.J. et al., 2003; Cheung A.K. et al., 2004]. The theoretical method of research was used. Many articles and dissertations by international scientists were analyzed, which were based on various books, dissertations, as well as electronic journals.
Keywords
Cardiovascular diseases, hemodynamic syndialysis stress, hemodialysis-induced myocardial ischemia, hyperhydration
References
Сабиров М. А., Салямова Ф. Э., Хусанходжаева Ф. Т. Нарушение сердечного ритма у больных с хронической болезнью почек V ст как предиктор сердечно-сосудистого риска. Published by “ CENTRAL ASIAN STUDIES" http://www.centralasianstudies.org. Volume: 03 Issue: 02 | Mar-Apr 2022 ISSN: 2660-4159. 193-196
СОВРЕМЕННЫЙ ПОДХОД К АНТИАГРЕГАНТНОМУ ЛЕЧЕНИЮ ПРИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК
Bikbov B.T., Tomilina N.A. Substitution therapy of patients with chronic renal insufficiency in the Russian Federation in 1998-2011. (Report according to the Russian Register of Renal Replacement Therapy. Part one). Nephrology and dialysis. 2014. 16(1): 11-127.
Bikbov B.T., Tomilina N.A. The state of substitution therapy in patients with chronic renal insufficiency in the Russian Federation in 1998-2005. Nephrology and dialysis, 2007. 9(1): 6-85.
Dudko M. Yu., Shutov E. V., Kapitanov E. N., Ermolenko V. M. The effect of water balance disorders on the state of the cardiovascular system in patients on renal replacement therapy. Nephrology and dialysis. 2006. (3): 244-249.
Ilyin A. P., Bogoyavlensky V. F., Gazizov R. M., Poletaev I. V. Myocardial dysfunction in patients with CRF at the age of over 55 years of age who are on programmed hemodialysis:
Features of diastolic and systolic dysfunction of hypertrophied myocardium and the effect of hemodialysis procedure on hemodynamic parameters. Nephrology and dialysis. 2001. 3(3): 365-369.
Korotky D. V., Makeeva T. I., Zavaritskaya O. P., Zemchenkov A. Yu. Arterial hypertension and myocardial hypertrophy at the predialysis stage of chronic kidney disease and with renal replacement therapy. Nephrology and dialysis. 2009. 11(3): 251-257.
Strokov A.G. Terekhov V.A. Gavrilin V.A. et al.
Intradialysis arterial hypotension and its prevention by monitoring the relative volume of blood.
Nephrology and dialysis. 2010. 12(4): 250-253.
Sharra B. Hemodialysis: "dry weight". the history
of the concept. Nephrology and dialysis. 1999. 1(2,3): 181-185.
Shutov A.M., Mastykov V. E., Edigarova O. M. Chronic dysfunction and intradialysis hypotension.
Neurology and dialysis. 2003. 5(2): 156-160.
Shutov A.M., Mastykov V. E., Edigarova O. M. Chronic heart failure in patients with chronic kidney disease. Nephrology and dialysis. 2005. 7(2): 140-144.
Shutov A.M., Ediganova O. M., Mastykov V. E. Assessment of left ventricular myocardial mass in patients on routine hemodialysis. Nephrology and dialysis. 2004. 6(2): 177-180.
Assa S., Hummel Y.M., Voors A.A. et al. Hemodialysis